Category: St. Jude Medical
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.
MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.
St. Jude Medical enrolls the 1st patient in a clinical trial of its next-generation Quadra Assura MP multi-point cardiac pacing system in patients with heart failure.
St. Jude Medical (NYSE:STJ) enrolled the 1st patient in a clinical study evaluating pacing in multiple points on the heart, the company announced today.
St. Jude Medical wins CE Mark approval in the European Union for its 1st-of-its-kind Allure Quadra quadripolar CRT pacemaker.
European regulators granted market approval to St. Jude Medical (NYSE:STJ) for its Allure Quadra quadripolar cardiac resynchronization therapy pacemaker, the medical device giant announced this week.
Changing expectations affect investors despite unchanged fundamentals: Weaker underlying volumes.
By Stephen Simpson
Shares of St. Jude Medical are down a day after the medical device company reported slowing sales and lowered its revenue outlook for the rest of the year.
Investors reacted to lowered sales expectations from St. Jude Medical (NYSE:STJ) by sending shares down nearly 2% today on Wall Street.
Volcano Corp. files another patent infringement lawsuit against St. Jude Medical over fractional flow reserve technology used to measure pressure within the heart's blood vessels.
Volcano (NSDQ:VOLC) and
Profits for medical device company St. Jude Medical rise during the 1st quarter, in the face of a 4% decrease in overall sales.
St. Jude Medical (NYSE:STJ) posted increased profits during the 1st quarter despite reporting lower sales.
The St. Paul-based medical device company said profits for the 3 months ended March 30 were $223 million, or 78¢ per share, on sales of $1.34 billion. That's a 5.2% bottom-line gain compared with Q1 2012, but a 4.1% top-line reduction.